Back to Zürcher Kantonalbank Zürcher Kantonalbank

SMMTSMMT

Showing 7 of 13 quarters

Position history for Zürcher KantonalbankZürcher Kantonalbank's holdings in Summit Therapeutics Inc.

No. Zürcher Kantonalbank exited its SMMT (Summit Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 424 shares worth $7,416. Zürcher Kantonalbank first reported SMMT in Q1 2023 and held it in 12 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$144,803

Total Shares Change

-6,612

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$18.96
0
2025-Q4
Unchanged
424
0.0%
$7,4160.0%$17.49
0
2025-Q3
Decreased
424
-32.5%
$8,7600.0%$20.66
0
2025-Q2
Decreased
628
-14.7%
$13,3640.0%$21.28
0
2025-Q1
Decreased
736
-86.6%
$14,1970.0%$19.29
0
2024-Q4
Decreased
5,486
-17.0%
$97,8980.0%$17.85
0
2024-Q3
Decreased
6,612
-2.2%
$144,8030.0%$20.89
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used